Your browser doesn't support javascript.
loading
2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
Persani, Luca; Rodien, Patrice; Moran, Carla; Edward Visser, W; Groeneweg, Stefan; Peeters, Robin; Refetoff, Samuel; Gurnell, Mark; Beck-Peccoz, Paolo; Chatterjee, Krishna.
Afiliação
  • Persani L; Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Rodien P; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano, Italy.
  • Moran C; Service d'Endocrinologie-Diabétologie-Nutrition, Centre de référence des maladies rares de la Thyroïde et des récepteurs hormonaux, CHU d'Angers, Angers, France.
  • Edward Visser W; Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
  • Groeneweg S; Endocrine Section, Beacon Hospital, Dublin, Ireland.
  • Peeters R; School of Medicine, University College Dublin, Ireland.
  • Refetoff S; Endocrinology Department, St Vincent's University Hospital, Dublin, Ireland.
  • Gurnell M; Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Beck-Peccoz P; Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Chatterjee K; Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eur Thyroid J ; 13(4)2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38963712
ABSTRACT
Impaired sensitivity to thyroid hormones encompasses disorders with defective transport of hormones into cells, reduced hormone metabolism, and resistance to hormone action. Mediated by heritable single-gene defects, these rare conditions exhibit different patterns of discordant thyroid function associated with multisystem phenotypes. In this context, challenges include ruling out other causes of biochemical discordance, making a diagnosis using clinical features together with the identification of pathogenic variants in causal genes, and managing these rare disorders with a limited evidence base. For each condition, the present guidelines aim to inform clinical practice by summarizing key clinical features and useful investigations, criteria for molecular genetic diagnosis, and pathways for management and therapy. Specific, key recommendations were developed by combining the best research evidence available with the knowledge and clinical experience of panel members, to achieve a consensus.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônios Tireóideos Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hormônios Tireóideos Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article